Tesamorelin (10mg) + Ipamorelin (2mg) is a dual-peptide research blend that combines a stabilized GHRH analog (Tesamorelin) with a selective ghrelin mimetic (Ipamorelin), designed for laboratory...
Tesamorelin (10mg) + Ipamorelin (2mg) is a dual-peptide research blend that combines a stabilized GHRH analog (Tesamorelin) with a selective ghrelin mimetic (Ipamorelin), designed for laboratory studies of growth hormone signaling and metabolic pathways. This formulation has been investigated in preclinical models to assess potential interactions between pituitary GHRH receptors and peripheral growth hormone secretagogue receptors, thereby influencing endocrine coordination and cellular energy regulation under controlled experimental conditions.
Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
Tesamorelin (10mg) + Ipamorelin (2mg) is a research-grade peptide combination that integrates two structurally distinct compounds with complementary biological roles. Tesamorelin, a stabilized GHRH analog, and Ipamorelin, a selective growth hormone secretagogue, are both composed of modified amino acids designed to enhance stability and functionality in laboratory settings.
Tesamorelin has a molecular weight of 5136 g/mol and a chemical formula of C₂₂₁H₃₆₆N₇₂O₆₇S, while Ipamorelin has a molecular weight of approximately 711.86 g/mol and a chemical formula of C₃₈H₄₉N₉O₅. This dual formulation has been studied for its role in endocrine signaling, metabolic regulation, and peptide-mediated cellular communication.
For laboratory research use only.
Tesamorelin (10mg) + Ipamorelin (2mg) is being researched for its combined effects on growth hormone signaling and metabolic regulation. In laboratory models, the two peptides are studied together to explore how distinct signaling mechanisms may interact within endocrine and metabolic systems.
Research applications often examine pathways related to energy balance, lipid metabolism, and the coordination of cellular signaling. The combination is also being investigated for its potential to influence hormone release dynamics and downstream metabolic responses in controlled environments.
These studies are typically conducted in in vitro systems and preclinical models, allowing researchers to observe how dual-peptide interactions affect biological processes at the cellular and systemic levels.
Preclinical research involving Tesamorelin and Ipamorelin has evaluated activity across microgram-per-kilogram (µg/kg) dosing ranges in animal models. In vitro studies commonly utilize defined concentration ranges to assess cellular responses and signaling activity.
Observed findings suggest that combining peptides with complementary mechanisms may influence biological pathways associated with hormone signaling, metabolic coordination, and cellular communication. These effects are dependent on study design and remain under investigation.
Laboratory data also indicate that peptide combinations may demonstrate coordinated or additive effects in controlled systems, supporting their use in mechanistic research exploring endocrine interactions.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals